In vitro Selection of DNA Aptamers to Glioblastoma Multiforme.

Aptamer probes for specific recognition of glioblastoma multiforme were generated using a repetitive and broad cell-SELEX-based procedure without negative selection. The 454 sequencing technology was used to monitor SELEX, and bioinformatics tools were used to identify aptamers from high throughput data. A group of aptamers were generated that can bind to target cells specifically with dissociation constants (K(d)) in the nanomolar range. Selected aptamers showed high affinity to different types of glioblastoma cell lines, while showing little or no affinity to other cancer cell lines. The aptamers generated in this study have potential use in different applications, such as probes for diagnosis and devices for targeted drug delivery, as well as tools for molecular marker discovery for glioblastomas.

[1]  Weihong Tan,et al.  Identification of liver cancer-specific aptamers using whole live cells. , 2008, Analytical chemistry.

[2]  G. Krauss,et al.  In vitro selection of DNA binding sites for ABF1 protein from Saccharomyces cerevisiae , 2005, FEBS letters.

[3]  L. Gold,et al.  Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. , 1990, Science.

[4]  Manju Patel,et al.  A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema. , 2005, Ophthalmology.

[5]  J. Szostak,et al.  Selection in vitro of single-stranded DNA molecules that fold into specific ligand-binding structures , 1992, Nature.

[6]  M. Kwon,et al.  In vitro selection of RNA against kanamycin B. , 2001, Molecules and cells.

[7]  Robert A. Meyers,et al.  Encyclopedia of analytical chemistry : applications, theory and instrumentation , 2000 .

[8]  N. Janjić,et al.  Novel approach to specific growth factor inhibition in vivo: antagonism of platelet-derived growth factor in glomerulonephritis by aptamers. , 1999, The American journal of pathology.

[9]  A. Kuno,et al.  RNA aptamers targeted to domain II of hepatitis C virus IRES that bind to its apical loop region. , 2003, Journal of biochemistry.

[10]  N. Janjić,et al.  Nuclease-resistant nucleic acid ligands to vascular permeability factor/vascular endothelial growth factor. , 1995, Chemistry & biology.

[11]  J. Tanner,et al.  Aptamer-mediated inhibition of Mycobacterium tuberculosis polyphosphate kinase 2. , 2011, Biochemistry.

[12]  J. Peccia,et al.  A DNA aptamer recognizes the Asp f 1 allergen of Aspergillus fumigatus. , 2009, Biochemical and biophysical research communications.

[13]  R. Landgraf,et al.  Inhibition of heregulin signaling by an aptamer that preferentially binds to the oligomeric form of human epidermal growth factor receptor-3 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[14]  Damian Labuda,et al.  In vitro evolution of RNA aptamers recognizing carcinogenic aromatic amines. , 2004, Biochemical and biophysical research communications.

[15]  Barry Merriman,et al.  U87MG Decoded: The Genomic Sequence of a Cytogenetically Aberrant Human Cancer Cell Line , 2010, PLoS genetics.

[16]  Laura A Lavery,et al.  Labeling tumor cells with fluorescent nanocrystal-aptamer bioconjugates. , 2006, Biosensors & bioelectronics.

[17]  J. Wills,et al.  Isolation of virus-neutralizing RNAs from a large pool of random sequences. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[18]  Jae Ho Lee,et al.  Selection and stabilization of the RNA aptamers against the human immunodeficiency virus type-1 nucleocapsid protein. , 2002, Biochemical and biophysical research communications.

[19]  Jacques Vergne,et al.  Adenine-Aptamer Complexes , 2002, The Journal of Biological Chemistry.

[20]  Kjell Hansson Mild,et al.  Long-term use of cellular phones and brain tumours: increased risk associated with use for ⩾10 years , 2007, Occupational and Environmental Medicine.

[21]  Robert Langer,et al.  An aptamer-doxorubicin physical conjugate as a novel targeted drug-delivery platform. , 2006, Angewandte Chemie.

[22]  Martin J. van den Bent,et al.  Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. , 2005, The New England journal of medicine.

[23]  M. Inui,et al.  In Vitro Selection and Characterization of DNA Aptamers Specific for Phospholamban , 2009, Journal of Pharmacology and Experimental Therapeutics.

[24]  Shun-ichiro Ogura,et al.  Selection of DNA aptamers recognizing small cell lung cancer using living cell-SELEX. , 2011, The Analyst.

[25]  Xin Li,et al.  Immunofluorescence assay and flow-cytometry selection of bead-bound aptamers. , 2003, Nucleic acids research.

[26]  Kiyoshi Asai,et al.  Antagonistic RNA aptamer specific to a heterodimeric form of human interleukin-17A/F. , 2011, Biochimie.

[27]  Michael Famulok,et al.  Molecular Recognition of Amino Acids by RNA-Aptamers: An L-Citrulline Binding RNA Motif and Its Evolution into an L-Arginine Binder , 1994 .

[28]  L. J. Maher,et al.  Selection and characterization of anti-NF-kappaB p65 RNA aptamers. , 2008, RNA.

[29]  Andrew D Ellington,et al.  Aptamer therapeutics advance. , 2006, Current opinion in chemical biology.

[30]  R A Bendele,et al.  Derivation of RNA aptamer inhibitors of human complement C5. , 1999, Immunopharmacology.

[31]  M. Radrizzani,et al.  Specific oligobodies against ERK-2 that recognize both the native and the denatured state of the protein. , 2001, Journal of immunological methods.

[32]  Paola Pisani,et al.  Genetic Pathways to Glioblastoma , 2004, Cancer Research.

[33]  J. Kjems,et al.  Serum-stable RNA aptamers to urokinase-type plasminogen activator blocking receptor binding. , 2010, RNA.

[34]  T. Sampson,et al.  Aptamers and SELEX: the technology , 2003 .

[35]  Jack W. Szostak,et al.  In vitro evolution of a self-alkylatlng ribozyme , 1995, Nature.

[36]  L. Gold,et al.  RNA aptamers to the peptidyl transferase inhibitor chloramphenicol. , 1997, Chemistry & biology.

[37]  A. Ellington,et al.  In vitro selection of RNA lectins: using combinatorial chemistry to interpret ribozyme evolution. , 1995, Chemistry & biology.

[38]  Sara Tombelli,et al.  New trends in affinity sensing: aptamers for ligand binding , 2003 .

[39]  C. Wilson,et al.  Inducible regulation of the S. cerevisiae cell cycle mediated by an RNA aptamer-ligand complex. , 2001, Bioorganic & medicinal chemistry.

[40]  Sean R. Eddy,et al.  ATV: display and manipulation of annotated phylogenetic , 2001, Bioinform..

[41]  M. Famulok,et al.  RNA aptamers specifically interact with the prion protein PrP , 1997, Journal of virology.

[42]  M. Bowser,et al.  SELEX: just another separation? , 2005, The Analyst.

[43]  Milan N Stojanovic,et al.  Fluorescent Sensors Based on Aptamer Self-Assembly. , 2000, Journal of the American Chemical Society.

[44]  U. Landegren,et al.  Protein detection using proximity-dependent DNA ligation assays , 2002, Nature Biotechnology.

[45]  P. S. Kim,et al.  Bioactive and nuclease-resistant L-DNA ligand of vasopressin. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[46]  R. Stoltenburg,et al.  SELEX--a (r)evolutionary method to generate high-affinity nucleic acid ligands. , 2007, Biomolecular engineering.

[47]  M. Ter‐Avanesyan,et al.  Selection of DNA aptamers specifically interacting with the fibrillar form of the yeast Sup35 protein , 2009, Molecular Biology.

[48]  G. Scoles,et al.  Control of steric hindrance on restriction enzyme reactions with surface-bound DNA nanostructures. , 2008, Nano letters.

[49]  K. Ang,et al.  Radiation Therapy Oncology Group (RTOG) Altered Fractionation Trials , 1995 .

[50]  D. Schoenfeld,et al.  Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas . A joint radiation therapy oncology group and eastern cooperative oncology group study , 1983, Cancer.

[51]  J. Rossi,et al.  Rev-binding aptamer and CMV promoter act as decoys to inhibit HIV replication. , 2000, Gene.

[52]  S. Rees,et al.  Generation of RNA aptamers to the G-protein-coupled receptor for neurotensin, NTS-1. , 2002, Analytical biochemistry.

[53]  E. Snyder,et al.  High-affinity RNA ligands to Escherichia coli ribosomes and ribosomal protein S1: comparison of natural and unnatural binding sites. , 1995, Biochemistry.

[54]  S. Yokoyama,et al.  In vitro selection of RNA aptamers that bind to colicin E3 and structurally resemble the decoding site of 16S ribosomal RNA. , 2004, Biochemistry.

[55]  D. Engelke,et al.  Selection of RNA aptamers that bind HIV-1 LTR DNA duplexes: strand invaders , 2010, Nucleic acids research.

[56]  G. Tocchini-Valentini,et al.  tRNA prefers to kiss , 1999, The EMBO journal.

[57]  Koji Sode,et al.  Selection of DNA aptamers against insulin and construction of an aptameric enzyme subunit for insulin sensing. , 2009, Biosensors & bioelectronics.

[58]  A. Aitken,et al.  The Generation and Characterization of Antagonist RNA Aptamers to Human Oncostatin M* , 2000, The Journal of Biological Chemistry.

[59]  George Quick,et al.  Antidote-mediated control of an anticoagulant aptamer in vivo , 2004, Nature Biotechnology.

[60]  G. Stormo,et al.  Combining SELEX with quantitative assays to rapidly obtain accurate models of protein–DNA interactions , 2005, Nucleic acids research.

[61]  B. Sullenger,et al.  Generation of species cross-reactive aptamers using "toggle" SELEX. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

[62]  J. Gariépy,et al.  DNA aptamers against the MUC1 tumour marker: design of aptamer–antibody sandwich ELISA for the early diagnosis of epithelial tumours , 2008, Analytical and bioanalytical chemistry.

[63]  J. Lis,et al.  Evolutionary dynamics and population control during in vitro selection and amplification with multiple targets. , 2002, RNA.

[64]  K. Gebhardt,et al.  RNA aptamers to S-adenosylhomocysteine: kinetic properties, divalent cation dependency, and comparison with anti-S-adenosylhomocysteine antibody. , 2000, Biochemistry.

[65]  H. Ozaki,et al.  Sialyllactose-binding modified DNA aptamer bearing additional functionality by SELEX. , 2004, Bioorganic & medicinal chemistry.

[66]  S. Jayasena,et al.  Oligonucleotide inhibitors of Taq DNA polymerase facilitate detection of low copy number targets by PCR. , 1996, Journal of molecular biology.

[67]  Jijun Tang,et al.  The DNA aptamers that specifically recognize ricin toxin are selected by two in vitro selection methods , 2006, Electrophoresis.

[68]  Michael Famulok,et al.  Stereospecific recognition of tryptophan agarose by in vitro selected RNA , 1992 .

[69]  R. Rando,et al.  Specific binding of aminoglycoside antibiotics to RNA. , 1995, Chemistry & biology.

[70]  C. Di Primo,et al.  In vitro selection of DNA aptamers against the HIV-1 TAR RNA hairpin. , 2002, Antisense & nucleic acid drug development.

[71]  B. Sullenger,et al.  RNA aptamers as reversible antagonists of coagulation factor IXa , 2002, Nature.

[72]  P. Bork,et al.  Functional organization of the yeast proteome by systematic analysis of protein complexes , 2002, Nature.

[73]  Ronald R. Breaker,et al.  In vitro selection and characterization of cellulose-binding DNA aptamers , 2007, Nucleic acids research.

[74]  D. Bigner,et al.  Glioblastoma multiforme: a review of where we have been and where we are going , 2009, Expert opinion on investigational drugs.

[75]  Weihong Tan,et al.  Study of the Molecular Recognition of Aptamers Selected through Ovarian Cancer Cell-SELEX , 2010, PloS one.

[76]  Bin Hu,et al.  Development of HBsAg-binding aptamers that bind HepG2.2.15 cells via HBV surface antigen , 2010, Virologica Sinica.

[77]  J. Szostak,et al.  In vitro selection of RNA aptamers specific for cyanocobalamin. , 1994, Biochemistry.

[78]  S. Rees,et al.  The generation and characterisation of antagonist RNA aptamers to MCP‐1 , 2001, FEBS letters.

[79]  L. Stewart,et al.  Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials , 2002, The Lancet.

[80]  Jean-Jacques Toulmé,et al.  Selective inhibitory DNA aptamers of the human RNase H1. , 2003, Nucleic acids research.

[81]  Intensity-modulated radiotherapy in high-grade gliomas: clinical and dosimetric results. , 2004, International journal of radiation oncology, biology, physics.

[82]  N. Banik,et al.  Differential sensitivity of human glioblastoma LN18 (PTEN-positive) and A172 (PTEN-negative) cells to Taxol for apoptosis , 2008, Brain Research.

[83]  Seong-Wook Lee,et al.  Identification of RNA aptamer specific to mutant KRAS protein. , 2010, Oligonucleotides.

[84]  Identification of potent and selective RNA antagonists of the IFN-gamma-inducible CXCL10 chemokine. , 2005, Biochemistry.

[85]  R. Breaker,et al.  Molecular recognition of cAMP by an RNA aptamer. , 2000, Biochemistry.

[86]  H. Schluesener,et al.  Systematic Evolution of a DNA Aptamer Binding to Rat Brain Tumor Microvessels , 2001, The Journal of Biological Chemistry.

[87]  Weihong Tan,et al.  DNA Aptamers as Molecular Probes for Colorectal Cancer Study , 2010, PloS one.

[88]  Man Bock Gu,et al.  ssDNA aptamers that selectively bind oxytetracycline. , 2008, Bioorganic & medicinal chemistry.

[89]  S. Watson,et al.  Isolation and characterization of 2'-fluoro-, 2'-amino-, and 2'-fluoro-/amino-modified RNA ligands to human IFN-gamma that inhibit receptor binding. , 1997, Journal of immunology.

[90]  Isolierung von RNA‐Aptameren für biologische Cofaktoren durch In‐vitro‐Selektion , 1994 .

[91]  A. Varki,et al.  DNA aptamers block L-selectin function in vivo. Inhibition of human lymphocyte trafficking in SCID mice. , 1996, The Journal of clinical investigation.

[92]  R. Stoltenburg,et al.  In vitro selection of DNA aptamers binding ethanolamine. , 2005, Biochemical and biophysical research communications.

[93]  H. Mihara,et al.  RNA aptamers selected against amyloid beta-peptide (Abeta) inhibit the aggregation of Abeta. , 2009, Molecular bioSystems.

[94]  Koichi Abe,et al.  Selection of DNA aptamer against prostate specific antigen using a genetic algorithm and application to sensing. , 2010, Biosensors & bioelectronics.

[95]  A. Kondo,et al.  Selection of a DNA aptamer that binds 8-OHdG using GMP-agarose. , 2009, Bioorganic & medicinal chemistry letters.

[96]  C. Ferreira,et al.  DNA Aptamers That Bind to MUC1 Tumour Marker: Design and Characterization of MUC1-Binding Single-Stranded DNA Aptamers , 2006, Tumor Biology.

[97]  Sheela M. Waugh,et al.  2′-Fluoropyrimidine RNA-based Aptamers to the 165-Amino Acid Form of Vascular Endothelial Growth Factor (VEGF165) , 1998, The Journal of Biological Chemistry.

[98]  Henning Ulrich,et al.  Disease‐specific biomarker discovery by aptamers , 2009, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[99]  Su Jin Lee,et al.  ssDNA aptamers that recognize diclofenac and 2-anilinophenylacetic acid. , 2009, Bioorganic & medicinal chemistry.

[100]  M. Famulok,et al.  A novel RNA motif for neomycin recognition. , 1995, Chemistry & biology.

[101]  Yun Xiang,et al.  Quantum-dot/aptamer-based ultrasensitive multi-analyte electrochemical biosensor. , 2006, Journal of the American Chemical Society.

[102]  P. Burgstaller,et al.  RNA aptamers that bind L-arginine with sub-micromolar dissociation constants and high enantioselectivity. , 1996, Nucleic acids research.

[103]  L. Gold,et al.  Selective enrichment of RNA species for tight binding to Escherichia coli rho factor , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[104]  A. Pardi,et al.  High-resolution molecular discrimination by RNA. , 1994, Science.

[105]  I. Majerfeld,et al.  Isoleucine:RNA sites with associated coding sequences. , 1998, RNA.

[106]  Won Jong Kim,et al.  Dual-aptamer-based delivery vehicle of doxorubicin to both PSMA (+) and PSMA (-) prostate cancers. , 2011, Biomaterials.

[107]  D. Patel,et al.  Adaptive recognition by nucleic acid aptamers. , 2000, Science.

[108]  Weihong Tan,et al.  Selection of DNA ligands for protein kinase C-delta. , 2006, Chemical communications.

[109]  A. Barfod,et al.  In vitro selection of RNA aptamers against a conserved region of the Plasmodium falciparum erythrocyte membrane protein 1 , 2009, Parasitology Research.

[110]  A. Van Schepdael,et al.  Selection and Characterization of DNA Aptamers for Egg White Lysozyme , 2010, Molecules.

[111]  W. Duan,et al.  RNA aptamer against a cancer stem cell marker epithelial cell adhesion molecule , 2011, Cancer science.

[112]  E. Alexander,et al.  Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial. , 1978, Journal of neurosurgery.

[113]  P. Richardson,et al.  An improved method for the in vitro evolution of aptamers and applications in protein detection and purification. , 2003, Nucleic acids research.

[114]  M. Famulok,et al.  Prion‐Protein‐Specific Aptamer Reduces PrPSc Formation , 2002, Chembiochem : a European journal of chemical biology.

[115]  Younghoon Lee,et al.  Probing the Functional Motifs of Escherichia coli 5S rRNA in Relation to 16S rRNA Using a SELEX Experiment , 1999 .

[116]  Ping Wang,et al.  DNA Aptamers That Bind to PrPC and Not PrpSc Show Sequence and Structure Specificity , 2006, Experimental biology and medicine.